• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

adequately 治疗的甲状腺功能减退症患者报告结局 - ThyDQoL、ThySRQ 和 ThyTSQ 德国版本的见解。

Patient-reported outcomes in adequately treated hypothyroidism - insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ.

机构信息

Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.

出版信息

Health Qual Life Outcomes. 2013 Apr 23;11:68. doi: 10.1186/1477-7525-11-68.

DOI:10.1186/1477-7525-11-68
PMID:23618009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3735043/
Abstract

BACKGROUND

Disease-specific patient-reported outcome measures (PROMs) have been developed as important research tools in the study of various diseases. For hypothyroidism there exist three validated disease-specific questionnaires in English: the Thyroid-Dependent Quality of Life Questionnaire (ThyDQoL), the Underactive Thyroid Symptom Rating Questionnaire (ThySRQ) and the Thyroid Treatment Satisfaction Questionnaire (ThyTSQ). We report psychometric properties of new German versions of the questionnaires including construct validity from two independent samples.

METHODS

230 envelopes with ThyDQoL, ThySRQ and ThyTSQ were given out to patients receiving levothyroxine for diagnosed hypothyroidism. Reliability and factor analyses were performed, correlations and hypothesised subgroup differences calculated to assess psychometric properties. Independently, 18 patients with treated hypothyroidism for autoimmune thyroiditis (Hashimoto’s disease) and 18 healthy control subjects were enrolled in a clinical study. Participants filled in the above questionnaires alongside well-known generic PROMs, e.g. the Beck Depression Inventory, the 12-item Well-Being Questionnaire and the Short-Form-36. Two blood samples were taken. Groups were compared and correlations between disease-specific and generic instruments analysed. Relationships between PROMs and biochemically determined thyroid hormone status were investigated.

RESULTS

102 patients returned completed questionnaires (response rate 44%). The newly translated questionnaires had satisfactory psychometric properties. Cronbach’s alpha was 0.92 for ThyDQoL, 0.81 for ThySRQ and 0.86 for ThyTSQ. For each of the questionnaires, a single factor structure explained the data best. Adequately treated patients with thyroid stimulating hormone levels in the upper normal range reported more symptoms in the ThySRQ. Those with autoimmune hypothyroidism reported being more bothered by depressive symptoms. Within the clinical sample, correlation with well-known generic instruments revealed good construct validity. In the clinical sample patients reported more symptoms in the ThySRQ, being more bothered by tiredness, higher depression and reduced well-being despite biochemically adequate treatment. Correlations between PROMs and biochemical thyroid hormone status revealed moderate though consistent associations.

CONCLUSIONS

Psychometric properties including construct validity of German versions of the ThyDQoL, ThySRQ and ThyTSQ are satisfactory. Feasibility and sensitivity in a clinical sample could be shown. We encourage the use of disease-specific PROMs in future studies as important additions to generic instruments in clinical research on hypothyroidism.

摘要

背景

特定于疾病的患者报告结局测量(PROMs)已作为研究各种疾病的重要研究工具得到发展。对于甲状腺功能减退症,有三种经过验证的特定于疾病的英语问卷:甲状腺依赖生活质量问卷(ThyDQoL)、甲状腺功能减退症状评分问卷(ThySRQ)和甲状腺治疗满意度问卷(ThyTSQ)。我们报告了新的德文版本问卷的心理测量特性,包括来自两个独立样本的构念效度。

方法

向接受左甲状腺素治疗的诊断为甲状腺功能减退症的患者发放了 230 个包含 ThyDQoL、ThySRQ 和 ThyTSQ 的信封。进行了可靠性和因子分析,计算了相关性和假设的亚组差异,以评估心理测量特性。独立地,招募了 18 名患有自身免疫性甲状腺炎(桥本氏病)的甲状腺功能减退症患者和 18 名健康对照者参加临床研究。参与者填写了上述问卷以及众所周知的通用 PROMs,例如贝克抑郁量表、12 项幸福感问卷和简短形式 36 项。采集了两份血样。比较了组间差异,并分析了特定于疾病的问卷和通用问卷之间的相关性。研究了 PROMs 与生化确定的甲状腺激素状态之间的关系。

结果

102 名患者返回了完整的问卷(应答率为 44%)。新翻译的问卷具有令人满意的心理测量特性。ThyDQoL 的 Cronbach's alpha 为 0.92,ThySRQ 为 0.81,ThyTSQ 为 0.86。对于每个问卷,单一的因子结构最好地解释了数据。促甲状腺激素水平在上限正常范围内的治疗充分的患者在 ThySRQ 中报告了更多的症状。自身免疫性甲状腺功能减退症患者报告说,抑郁症状更困扰他们。在临床样本中,与众所周知的通用工具的相关性显示出良好的构念效度。在临床样本中,患者在 ThySRQ 中报告了更多的症状,疲劳感更强,抑郁程度更高,幸福感降低,尽管生化治疗充分。PROMs 与生化甲状腺激素状态之间的相关性显示出中等但一致的关联。

结论

德文版本的 ThyDQoL、ThySRQ 和 ThyTSQ 的心理测量特性,包括构念效度,均令人满意。在临床样本中证明了可行性和敏感性。我们鼓励在未来的研究中使用特定于疾病的 PROMs,作为临床研究甲状腺功能减退症中通用工具的重要补充。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac01/3735043/fd8c811b6ba6/1477-7525-11-68-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac01/3735043/fd8c811b6ba6/1477-7525-11-68-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac01/3735043/fd8c811b6ba6/1477-7525-11-68-1.jpg

相似文献

1
Patient-reported outcomes in adequately treated hypothyroidism - insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ. adequately 治疗的甲状腺功能减退症患者报告结局 - ThyDQoL、ThySRQ 和 ThyTSQ 德国版本的见解。
Health Qual Life Outcomes. 2013 Apr 23;11:68. doi: 10.1186/1477-7525-11-68.
2
Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ.评估甲状腺功能减退对生活质量和症状影响的新指标:甲状腺疾病生活质量量表(ThyDQoL)和甲状腺疾病症状自评量表(ThySRQ)。
Value Health. 2008 Mar-Apr;11(2):285-94. doi: 10.1111/j.1524-4733.2007.00232.x.
3
Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism.用于测量甲状腺功能减退症患者生活质量和治疗满意度的新问卷设计。
Thyroid. 2004 Nov;14(11):916-25. doi: 10.1089/thy.2004.14.916.
4
Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: the ThyTSQ.一种用于评估甲状腺功能减退症治疗满意度的新问卷(ThyTSQ)的心理测量学评价。
Value Health. 2006 Mar-Apr;9(2):132-9. doi: 10.1111/j.1524-4733.2006.00091.x.
5
Psychometric properties of the quality of life in short statured youth (QoLISSY) questionnaire within the course of growth hormone treatment.生长激素治疗过程中青少年特发性身材矮小生活质量问卷(QoLISSY)的心理测量特性。
Health Qual Life Outcomes. 2019 Mar 18;17(1):49. doi: 10.1186/s12955-019-1118-9.
6
Evaluation of smoking-specific and generic quality of life measures in current and former smokers in Germany and the United States.德国和美国当前吸烟者及既往吸烟者的吸烟特异性和一般生活质量测量评估。
Health Qual Life Outcomes. 2015 Aug 16;13:128. doi: 10.1186/s12955-015-0316-3.
7
Psychometric validation of the French self and proxy versions of the PedsQL™ 4.0 generic health-related quality of life questionnaire for 8-12 year-old children.8-12 岁儿童 PedsQLTM 4.0 通用健康相关生活质量问卷自评和代评法语版的心理测量学验证。
Health Qual Life Outcomes. 2021 Mar 4;19(1):75. doi: 10.1186/s12955-021-01714-y.
8
A systematic review of quality of thyroid-specific health-related quality-of-life instruments recommends ThyPRO for patients with benign thyroid diseases.一项关于甲状腺特异性健康相关生活质量工具质量的系统评价推荐ThyPRO用于患有良性甲状腺疾病的患者。
J Clin Epidemiol. 2016 Oct;78:63-72. doi: 10.1016/j.jclinepi.2016.03.006. Epub 2016 Mar 26.
9
Validity and reliability of new instruments for measuring patient satisfaction with removable dentures, Arabic Version.新的可摘义齿患者满意度测量工具的信度和效度研究,阿拉伯语版。
BMC Oral Health. 2021 Sep 15;21(1):446. doi: 10.1186/s12903-021-01811-w.
10
Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment.《眼药满意度问卷》(EDSQ)的评分和心理测量学特性,该工具用于评估青光眼治疗的满意度和依从性。
BMC Ophthalmol. 2010 Feb 1;10:1. doi: 10.1186/1471-2415-10-1.

引用本文的文献

1
Psychological factors and obesity, not thyroid biomarkers, predict thyroid-dependent quality of life in treated hypothyroidism: a cross-sectional study.心理因素和肥胖,而非甲状腺生物标志物,可预测接受治疗的甲状腺功能减退症患者依赖甲状腺的生活质量:一项横断面研究。
BMC Endocr Disord. 2025 May 26;25(1):136. doi: 10.1186/s12902-025-01962-9.
2
Evaluating health outcomes in the treatment of hypothyroidism.评估甲状腺功能减退症治疗中的健康结局。
Front Endocrinol (Lausanne). 2022 Oct 18;13:1026262. doi: 10.3389/fendo.2022.1026262. eCollection 2022.
3
Thyroid disease-specific quality of life questionnaires - A systematic review.

本文引用的文献

1
Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.成人甲状腺功能减退症临床实践指南:由美国临床内分泌医师学会和美国甲状腺协会共同赞助。
Endocr Pract. 2012 Nov-Dec;18(6):988-1028. doi: 10.4158/EP12280.GL.
2
Positive thyroid peroxidase antibody titer is associated with dysphoric moods during pregnancy and postpartum.甲状腺过氧化物酶抗体滴度呈阳性与孕期及产后的烦躁情绪有关。
J Obstet Gynecol Neonatal Nurs. 2013 Jan-Feb;42(1):E26-32. doi: 10.1111/j.1552-6909.2012.01425.x. Epub 2012 Nov 20.
3
Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism?
甲状腺疾病特异性生活质量调查问卷 - 系统评价。
Endocrinol Diabetes Metab. 2022 Sep;5(5):e357. doi: 10.1002/edm2.357. Epub 2022 Jul 20.
4
Hypothyroidism.甲状腺功能减退症。
Nat Rev Dis Primers. 2022 May 19;8(1):30. doi: 10.1038/s41572-022-00357-7.
5
Primary hypothyroidism and quality of life.原发性甲状腺功能减退症与生活质量。
Nat Rev Endocrinol. 2022 Apr;18(4):230-242. doi: 10.1038/s41574-021-00625-8. Epub 2022 Jan 18.
6
What Is the Quality of Life in Patients Treated with Levothyroxine for Hypothyroidism and How Are We Measuring It? A Critical, Narrative Review.左甲状腺素治疗甲状腺功能减退症患者的生活质量如何,我们又是如何衡量的?一项批判性叙述性综述。
J Clin Med. 2021 Mar 30;10(7):1386. doi: 10.3390/jcm10071386.
7
Health-Related Quality of Life in Levothyroxine-Treated Hypothyroid Women and Women without Hypothyroidism: A Case-Control Study.左甲状腺素治疗的甲状腺功能减退女性与非甲状腺功能减退女性的健康相关生活质量:一项病例对照研究。
J Clin Med. 2020 Nov 27;9(12):3864. doi: 10.3390/jcm9123864.
8
No Effect of Thyroid Dysfunction and Autoimmunity on Health-Related Quality of Life and Mental Health in Children and Adolescents: Results From a Nationwide Cross-Sectional Study.甲状腺功能障碍和自身免疫对儿童和青少年健康相关生活质量和心理健康的影响:来自全国性横断面研究的结果。
Front Endocrinol (Lausanne). 2020 Sep 2;11:454. doi: 10.3389/fendo.2020.00454. eCollection 2020.
9
The acceptance and applicability of a patient-reported experience measurement tool in oncological care: a descriptive feasibility study in northern Germany.患者报告的体验测量工具在肿瘤学护理中的接受度和适用性:德国北部的一项描述性可行性研究。
BMC Health Serv Res. 2019 Nov 1;19(1):786. doi: 10.1186/s12913-019-4646-4.
10
Functional and Symptomatic Individuality in the Response to Levothyroxine Treatment.左甲状腺素治疗反应中的功能和症状个体差异。
Front Endocrinol (Lausanne). 2019 Sep 26;10:664. doi: 10.3389/fendo.2019.00664. eCollection 2019.
T4 与 T3 联合治疗:走向甲状腺功能减退症的个体化替代治疗?
J Clin Endocrinol Metab. 2012 Jul;97(7):2256-71. doi: 10.1210/jc.2011-3399. Epub 2012 May 16.
4
The epidemiology of thyroid disease.甲状腺疾病的流行病学。
Br Med Bull. 2011;99:39-51. doi: 10.1093/bmb/ldr030.
5
Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter.桥本甲状腺炎影响甲状腺功能正常女性的症状负担和生活质量:一项针对良性甲状腺肿行甲状腺切除术患者的前瞻性病例对照研究。
Thyroid. 2011 Feb;21(2):161-7. doi: 10.1089/thy.2010.0191. Epub 2010 Dec 27.
6
Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy.甲状腺功能减退症患者的脑葡萄糖代谢:甲状腺激素替代治疗前后的正电子发射断层扫描研究
J Clin Endocrinol Metab. 2009 Aug;94(8):2922-9. doi: 10.1210/jc.2008-2235. Epub 2009 May 12.
7
Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.DIO2基因的常见变异可预测甲状腺功能减退患者的基线心理健康状况以及对甲状腺素联合三碘甲状腺原氨酸治疗的反应。
J Clin Endocrinol Metab. 2009 May;94(5):1623-9. doi: 10.1210/jc.2008-1301. Epub 2009 Feb 3.
8
Reference intervals for TSH and thyroid hormones are mainly affected by age, body mass index and number of blood leucocytes, but hardly by gender and thyroid autoantibodies during the first decades of life.促甲状腺激素(TSH)和甲状腺激素的参考区间主要受年龄、体重指数和血液白细胞数量的影响,但在生命的最初几十年里,几乎不受性别和甲状腺自身抗体的影响。
Clin Biochem. 2008 Sep;41(13):1091-8. doi: 10.1016/j.clinbiochem.2008.04.007. Epub 2008 Apr 23.
9
Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ.评估甲状腺功能减退对生活质量和症状影响的新指标:甲状腺疾病生活质量量表(ThyDQoL)和甲状腺疾病症状自评量表(ThySRQ)。
Value Health. 2008 Mar-Apr;11(2):285-94. doi: 10.1111/j.1524-4733.2007.00232.x.
10
[Substitution of thyroid hormones].[甲状腺激素替代治疗]
Internist (Berl). 2008 May;49(5):538, 540-4. doi: 10.1007/s00108-008-2109-9.